Monitoring how T cells respond to HIV
Inside these squares, single T cells taken from HIV-infected patients interact with infected cells. This technology, developed by MIT chemical engineers, offers the first way to study how effectively individual T cells respond to HIV-infected cells. Image: Navin Varadarajan
One of the obstacles to developing an effective AIDS vaccine is the difficulty in measuring how well a potential vaccine primes the body to defend itself against HIV.
Ideally, scientists would like their vaccines to provoke T cells, a critical component of the immune response, to recognize and kill HIV-infected cells. Unfortunately, there is no fast and easy way to monitor whether T cells are actually doing that. Instead, researchers measure the amount of a protein called interferon gamma that T cells secrete when they encounter an infected cell. Studies have shown, however, that this surrogate measurement doesnt necessarily predict a T cells ability to kill HIV-infected cells.
In an advance that could overcome that obstacle, a team of researchers at MIT has developed a new technology that can measure multiple aspects of individual T cells responses to HIV-infected cells, including their ability to kill them. The technology could make it easier to monitor and design vaccines against HIV, says J. Christopher Love, the Latham Family Career Development Associate Professor of Chemical Engineering and leader of the research team.
The technology, described in a paper published in the Oct. 3 online edition of the Journal of Clinical Investigation, involves two steps. First, the researchers place single T cells taken from HIV-infected patients into tiny wells on a plate, where they are exposed to HIV-infected cells. The researchers can detect whether the T cells kill the infected cells with probes that glow when the dying cells nuclei become compromised.
Watch T cells attack HIV-infected cells:
This video is not supported by your browser at this time.Next, the researchers measure interferon gamma production with a microengraving technique they developed in 2008. Secretions from each cell are imprinted on a glass slide, which can then be tested for the presence of specific proteins. Because each cell has its own address on the slide, the secretions can be traced back to individual cells, and their interferon gamma production can be correlated directly to their cell-killing ability.
The same technology could be adapted to measure cells output of any other immune system protein.
In this study, the researchers found that while the percentage of T cells that secrete interferon gamma is similar to the percentage of those that kill infected cells, the populations are not identical. In future studies, the researchers hope to find markers that do correlate with cell-killing ability, making it easier to evaluate a potential vaccines effectiveness.
Now that we have a tool to look directly at a variety of different functional activities, you can go in and start to evaluate other markers that may be better predictors of killing. Those then become what you would want to monitor in vaccine trials, says Love, who is also a member of the Ragon Institute of MGH, MIT and Harvard and the David H. Koch Institute for Integrative Cancer Research at MIT.
The appeal of this technology is that it can help us understand more about whats going on in single cells, says Alan Landay, professor of immunology and microbiology at Rush Medical College. It helps us rethink what we understand about immunology and immune function.
More research will be needed to develop the technology to the point where it can be used routinely in vaccine trials for large-scale studies of patient samples.
This story is republished courtesy of MIT News (web.mit.edu/newsoffice/), a popular site that covers news about MIT research, innovation and teaching.
Provided by Massachusetts Institute of Technology
- Well-armed immune cells help long-term non-progressors contain HIV Dec 04, 2008 | not rated yet | 0
- Nano-sized vaccines Feb 22, 2011 | not rated yet | 0
- Extraordinary immune cells may hold the key to managing HIV Dec 04, 2008 | not rated yet | 0
- Elite controllers block integration of HIV DNA into host genome Sep 19, 2011 | not rated yet | 0
- Exhausted B cells hamper immune response to HIV Jul 14, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
HIV & AIDS 6 hours ago | 5 / 5 (3) | 0 |
Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies ...
HIV & AIDS 22 hours ago | 5 / 5 (1) | 0
(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Intern ...
HIV & AIDS May 22, 2013 | not rated yet | 0
Canadian health authorities lifted Wednesday what was effectively a ban on gay men giving blood, announcing new rules making men who have not had sex with men in the past five years eligible.
HIV & AIDS May 22, 2013 | not rated yet | 1
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
49 minutes ago | not rated yet | 0 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
18 minutes ago | not rated yet | 0
(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.
44 minutes ago | not rated yet | 0
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
3 hours ago | 5 / 5 (1) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
3 hours ago | 5 / 5 (2) | 0 |
Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.
1 hour ago | not rated yet | 0